(+)-catechin increases expression ISO RGD:735727 6480464 Catechin results in increased expression of PLAU mRNA; more ... CTD PMID:11236827 (+)-catechin increases expression EXP 6480464 Catechin results in increased expression of PLAU mRNA CTD PMID:17478321 (+)-catechin multiple interactions ISO RGD:735727 6480464 Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAU mRNA] CTD PMID:11236827 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:735727 6480464 epigallocatechin gallate results in decreased expression of PLAU mRNA CTD PMID:16084531 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLAU mRNA CTD PMID:25729387 (S)-nicotine multiple interactions ISO RGD:735727 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of PLAU mRNA] CTD PMID:20061081 (S)-nicotine multiple interactions ISO RGD:733174 6480464 PLAU inhibits the reaction [Nicotine binds to CHRNA1 protein] CTD PMID:19690163 (S)-nicotine increases expression ISO RGD:735727 6480464 Nicotine results in increased expression of PLAU mRNA CTD PMID:20061081 PMID:23825647 1,1-dichloroethene decreases expression ISO RGD:733174 6480464 vinylidene chloride results in decreased expression of PLAU mRNA CTD PMID:26682919 1,10-phenanthroline multiple interactions ISO RGD:733174 6480464 1,10-phenanthroline inhibits the reaction [PLAU protein results in increased activity of MMP9 protein] CTD PMID:20177776 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PLAU mRNA CTD PMID:25380136 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:735727 6480464 gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mRNA]; more ... CTD PMID:23127547 1-octadec-9-enoylglycero-3-phosphate increases expression ISO RGD:735727 6480464 lysophosphatidic acid results in increased expression of PLAU mRNA CTD PMID:23127547 17beta-estradiol decreases expression ISO RGD:735727 6480464 Estradiol results in decreased expression of PLAU mRNA CTD PMID:23019147 PMID:25321415 17beta-estradiol multiple interactions ISO RGD:735727 6480464 [Estradiol binds to ESR2 protein] which results in decreased expression of PLAU mRNA; more ... CTD PMID:17404688 more ... 17beta-estradiol affects expression ISO RGD:735727 6480464 Estradiol affects the expression of PLAU mRNA CTD PMID:14699072 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733174 6480464 [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of PLAU mRNA CTD PMID:21167638 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733174 6480464 Tetrachlorodibenzodioxin results in increased expression of PLAU mRNA CTD PMID:21041162 PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735727 6480464 Tetrachlorodibenzodioxin results in increased expression of PLAU mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases stability EXP 6480464 Tetrachlorodibenzodioxin results in increased stability of PLAU mRNA CTD PMID:10833433 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733174 6480464 Tetrachlorodibenzodioxin affects the expression of PLAU mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLAU protein CTD PMID:12128104 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 CGA protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLAU protein] CTD PMID:12128104 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLAU mRNA CTD PMID:15644576 3,3'-diindolylmethane increases expression ISO RGD:735727 6480464 3,3'-diindolylmethane results in increased expression of PLAU mRNA CTD PMID:18025290 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:735727 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of PLAU mRNA] CTD PMID:20061081 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735727 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLAU mRNA; more ... CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:735727 6480464 Methylcholanthrene results in increased expression of PLAU mRNA CTD PMID:16619036 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4,4'-diaminodiphenylmethane results in increased expression of PLAU mRNA CTD PMID:25380136 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO RGD:733174 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PLAU mRNA CTD PMID:21167638 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:733174 6480464 [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of PLAU mRNA CTD PMID:21167638 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735727 6480464 [decitabine affects the methylation of PLAU promoter] which affects the expression of PLAU mRNA; more ... CTD PMID:18320071 PMID:21167264 5-aza-2'-deoxycytidine affects expression ISO RGD:735727 6480464 decitabine affects the expression of PLAU mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression ISO RGD:735727 6480464 decitabine results in increased expression of PLAU mRNA CTD PMID:16367923 PMID:18025290 5-fluorouracil affects expression ISO RGD:735727 6480464 Fluorouracil affects the expression of PLAU mRNA CTD PMID:16584549 7,12-dimethyltetraphene increases expression ISO RGD:735727 6480464 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLAU mRNA CTD PMID:21527772 acetaldehyde multiple interactions EXP 6480464 TGFB1 protein inhibits the reaction [Acetaldehyde results in increased expression of PLAU protein] CTD PMID:15452360 acetaldehyde increases expression EXP 6480464 Acetaldehyde results in increased expression of PLAU mRNA; more ... CTD PMID:10513995 PMID:15452360 acetaldehyde affects activity EXP 6480464 Acetaldehyde affects the activity of PLAU protein CTD PMID:10513995 actinomycin D multiple interactions ISO RGD:735727 6480464 Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAU mRNA]; more ... CTD PMID:11236827 actinomycin D increases expression ISO RGD:735727 6480464 Dactinomycin results in increased expression of PLAU mRNA CTD PMID:21527772 aflatoxin B1 increases expression ISO RGD:735727 6480464 Aflatoxin B1 results in increased expression of PLAU protein CTD PMID:21527772 all-trans-retinoic acid decreases expression ISO RGD:735727 6480464 Tretinoin results in decreased expression of PLAU mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:735727 6480464 Tretinoin results in increased expression of PLAU mRNA CTD PMID:23830798 amiloride multiple interactions ISO RGD:735727 6480464 Amiloride inhibits the reaction [PLAU protein results in increased degradation of PLG protein] CTD PMID:14644129 amiloride decreases activity ISO RGD:735727 6480464 Amiloride results in decreased activity of PLAU protein CTD PMID:11454671 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLAU mRNA CTD PMID:16483693 anethole decreases expression ISO RGD:735727 6480464 anethole results in decreased expression of PLAU mRNA CTD PMID:21212515 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:735727 6480464 pyrazolanthrone inhibits the reaction [TNF protein results in increased activity of PLAU protein]; more ... CTD PMID:19874453 PMID:23437203 antirheumatic drug decreases expression ISO RGD:735727 6480464 Antirheumatic Agents results in decreased expression of PLAU mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:735727 6480464 arsenic trioxide results in increased expression of PLAU mRNA CTD PMID:20458559 arsenous acid decreases expression ISO RGD:735727 6480464 arsenic trioxide results in decreased expression of PLAU mRNA CTD PMID:15962302 more ... arsenous acid multiple interactions ISO RGD:735727 6480464 [silybin co-treated with arsenic trioxide] results in decreased expression of PLAU mRNA; more ... CTD PMID:15962302 more ... atorvastatin calcium decreases expression ISO RGD:735727 6480464 Atorvastatin Calcium results in decreased expression of PLAU protein CTD PMID:16410222 ATP increases secretion ISO RGD:733174 6480464 Adenosine Triphosphate results in increased secretion of PLAU protein CTD PMID:20177776 azelaic acid decreases expression ISO RGD:735727 6480464 azelaic acid results in decreased expression of PLAU mRNA CTD PMID:8635147 azelaic acid multiple interactions ISO RGD:735727 6480464 azelaic acid results in decreased expression of and results in decreased secretion of PLAU protein CTD PMID:8635147 baicalein decreases activity ISO RGD:735727 6480464 baicalein results in decreased activity of PLAU protein CTD PMID:21803068 belinostat increases expression ISO RGD:735727 6480464 belinostat results in increased expression of PLAU mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:735727 6480464 [NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAU mRNA CTD PMID:27188386 benazepril multiple interactions EXP 6480464 benazepril inhibits the reaction [Streptozocin results in increased expression of PLAU mRNA] CTD PMID:15322501 benomyl decreases expression ISO RGD:735727 6480464 Benomyl results in decreased expression of PLAU mRNA CTD PMID:25530041 benzo[a]pyrene affects expression ISO RGD:733174 6480464 Benzo(a)pyrene affects the expression of PLAU mRNA CTD PMID:22342234 benzo[a]pyrene increases expression ISO RGD:735727 6480464 Benzo(a)pyrene results in increased expression of PLAU mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:733174 6480464 Benzo(a)pyrene results in increased expression of PLAU mRNA CTD PMID:22228805 PMID:22610609 benzo[b]fluoranthene increases expression ISO RGD:733174 6480464 benzo(b)fluoranthene results in increased expression of PLAU mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:733174 6480464 Dexamethasone inhibits the reaction [Mustard Gas results in increased activity of PLAU protein]; more ... CTD PMID:9101041 bis(2-chloroethyl) sulfide increases expression ISO RGD:733174 6480464 Mustard Gas results in increased expression of PLAU mRNA CTD PMID:9101041 bisdemethoxycurcumin decreases secretion ISO RGD:735727 6480464 bis(4-hydroxycinnamoyl)methane results in decreased secretion of PLAU protein CTD PMID:18495463 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLAU mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:735727 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLAU mRNA CTD PMID:28628672 bisphenol A increases expression ISO RGD:735727 6480464 bisphenol A results in increased expression of PLAU mRNA CTD PMID:27685785 bisphenol F multiple interactions ISO RGD:735727 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PLAU mRNA CTD PMID:28628672 bleomycin A2 increases expression ISO RGD:733174 6480464 Bleomycin results in increased expression of PLAU mRNA; more ... CTD PMID:25648892 bleomycin A2 decreases expression ISO RGD:733174 6480464 Bleomycin results in decreased expression of PLAU protein CTD PMID:25648892 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of PLAU mRNA CTD PMID:17327699 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PLAU mRNA CTD PMID:17327699 capsaicin increases expression ISO RGD:735727 6480464 Capsaicin results in increased expression of PLAU mRNA CTD PMID:21310942 carbamazepine affects expression ISO RGD:735727 6480464 Carbamazepine affects the expression of PLAU mRNA CTD PMID:25979313 carbendazim decreases expression ISO RGD:735727 6480464 carbendazim results in decreased expression of PLAU mRNA CTD PMID:25530041 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of PLAU mRNA CTD PMID:20211217 carbon nanotube affects expression ISO RGD:735727 6480464 Nanotubes, Carbon affects the expression of PLAU mRNA CTD PMID:25790727 carbon nanotube increases expression ISO RGD:733174 6480464 Nanotubes, Carbon analog results in increased expression of PLAU mRNA; more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:735727 6480464 Nanotubes, Carbon results in increased expression of PLAU protein CTD PMID:25790727 carbon nanotube decreases expression ISO RGD:735727 6480464 Nanotubes, Carbon results in decreased expression of PLAU mRNA CTD PMID:23634900 carbon nanotube multiple interactions ISO RGD:735727 6480464 [Nanotubes, Carbon co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] results in decreased expression of PLAU protein CTD PMID:25790727 casticin decreases expression ISO RGD:733174 6480464 casticin results in decreased expression of PLAU protein CTD PMID:28444820 chloropicrin affects expression ISO RGD:735727 6480464 chloropicrin affects the expression of PLAU mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:733174 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAU mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PLAU mRNA CTD PMID:22023808 cisplatin affects expression ISO RGD:735727 6480464 Cisplatin affects the expression of PLAU mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:735727 6480464 Cisplatin results in increased expression of PLAU mRNA CTD PMID:27594783 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of PLAU mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:735727 6480464 cobaltous chloride results in decreased expression of PLAU mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:735727 6480464 Copper Sulfate results in increased expression of PLAU mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:735727 6480464 Asbestos, Crocidolite results in decreased expression of PLAU mRNA CTD PMID:23634900 crocidolite asbestos increases expression ISO RGD:735727 6480464 Asbestos, Crocidolite results in increased expression of PLAU mRNA CTD PMID:18687144 PMID:25351596 curcumin decreases secretion ISO RGD:735727 6480464 Curcumin results in decreased secretion of PLAU protein CTD PMID:18495463 curcumin increases expression ISO RGD:735727 6480464 Curcumin results in increased expression of PLAU mRNA CTD PMID:18025290 curcumin multiple interactions ISO RGD:735727 6480464 TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of PLAU protein] CTD PMID:18226269 curcumin decreases expression ISO RGD:735727 6480464 Curcumin results in decreased expression of PLAU protein CTD PMID:18226269 cyclophosphamide increases expression ISO RGD:735727 6480464 Cyclophosphamide results in increased expression of PLAU mRNA CTD PMID:21527772 demethoxycurcumin decreases secretion ISO RGD:735727 6480464 demethoxycurcumin results in decreased secretion of PLAU protein CTD PMID:18495463 desferrioxamine B multiple interactions ISO RGD:735727 6480464 Deferoxamine inhibits the reaction [ferric nitrilotriacetate results in increased activity of PLAU mRNA]; more ... CTD PMID:17571974 dexamethasone decreases expression ISO RGD:735727 6480464 Dexamethasone results in decreased expression of PLAU mRNA; more ... CTD PMID:10467400 PMID:25047013 dexamethasone multiple interactions ISO RGD:735727 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLAU mRNA; more ... CTD PMID:28628672 dexamethasone increases expression ISO RGD:733174 6480464 Dexamethasone results in increased expression of PLAU mRNA CTD PMID:21041162 dexamethasone decreases activity ISO RGD:735727 6480464 Dexamethasone results in decreased activity of PLAU protein CTD PMID:10455257 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of PLAU protein CTD PMID:10485340 dexamethasone multiple interactions ISO RGD:733174 6480464 Dexamethasone inhibits the reaction [Mustard Gas results in increased activity of PLAU protein]; more ... CTD PMID:9101041 diarsenic trioxide increases expression ISO RGD:735727 6480464 arsenic trioxide results in increased expression of PLAU mRNA CTD PMID:20458559 diarsenic trioxide decreases expression ISO RGD:735727 6480464 arsenic trioxide results in decreased expression of PLAU mRNA CTD PMID:15962302 more ... diarsenic trioxide multiple interactions ISO RGD:735727 6480464 [silybin co-treated with arsenic trioxide] results in decreased expression of PLAU mRNA; more ... CTD PMID:15962302 more ... diclofenac increases expression ISO RGD:733174 6480464 Diclofenac results in increased expression of PLAU protein CTD PMID:23506792 dioxygen multiple interactions ISO RGD:733174 6480464 Oxygen deficiency promotes the reaction [PLAU protein results in increased activity of PLG protein] CTD PMID:12485432 dioxygen increases expression ISO RGD:733174 6480464 Oxygen deficiency results in increased expression of PLAU mRNA CTD PMID:12485432 dioxygen increases activity ISO RGD:733174 6480464 Oxygen deficiency results in increased activity of PLAU protein CTD PMID:12485432 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PLAU mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:735727 6480464 [NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAU mRNA; more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:735727 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased expression of PLAU mRNA]; more ... CTD PMID:12908082 PMID:15557793 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of PLAU mRNA CTD PMID:20211217 doxorubicin affects response to substance ISO RGD:735727 6480464 PLAU protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases response to substance ISO RGD:735727 6480464 PLAU promoter modified form results in decreased susceptibility to Doxorubicin CTD PMID:16356834 doxorubicin increases expression ISO RGD:735727 6480464 Doxorubicin results in increased expression of PLAU mRNA; more ... CTD PMID:15557793 entinostat increases expression ISO RGD:735727 6480464 entinostat results in increased expression of PLAU mRNA CTD PMID:27188386 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PLAU mRNA CTD PMID:15353170 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PLAU mRNA CTD PMID:17478321 etoposide increases expression ISO RGD:735727 6480464 Etoposide results in increased expression of PLAU mRNA CTD PMID:21527772 fenamidone increases expression ISO RGD:733174 6480464 fenamidone results in increased expression of PLAU mRNA CTD PMID:27029645 flavonol decreases expression ISO RGD:735727 6480464 3-hydroxyflavone results in decreased expression of PLAU protein CTD PMID:27600294 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PLAU mRNA CTD PMID:24793618 folic acid affects expression ISO RGD:735727 6480464 Folic Acid affects the expression of PLAU mRNA CTD PMID:16361273 folic acid multiple interactions ISO RGD:733174 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAU mRNA CTD PMID:20938992 furan increases methylation EXP 6480464 furan results in increased methylation of PLAU gene CTD PMID:22079235 furan increases expression EXP 6480464 furan results in increased expression of PLAU mRNA CTD PMID:27387713 gefitinib multiple interactions ISO RGD:735727 6480464 gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mRNA]; more ... CTD PMID:23127547 geldanamycin multiple interactions ISO RGD:735727 6480464 [geldanamycin co-treated with PTHLH protein modified form] results in decreased expression of PLAU mRNA CTD PMID:12724357 gemcitabine increases expression ISO RGD:735727 6480464 gemcitabine results in increased expression of PLAU mRNA CTD PMID:17039268 genistein increases expression ISO RGD:735727 6480464 Genistein results in increased expression of PLAU mRNA CTD PMID:18025290 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of PLAU mRNA CTD PMID:21782745 genistein decreases expression ISO RGD:735727 6480464 Genistein results in decreased expression of PLAU mRNA CTD PMID:23019147 genistein increases expression EXP 6480464 Genistein results in increased expression of PLAU protein CTD PMID:17823541 heparin decreases expression ISO RGD:735727 6480464 Heparin analog results in decreased expression of PLAU mRNA CTD PMID:26476401 hyaluronic acid multiple interactions ISO RGD:735727 6480464 [Hyaluronic Acid analog binds to and results in increased activity of CD44 protein] which results in increased expression of PLAU mRNA; more ... CTD PMID:12402308 ibuprofen multiple interactions ISO RGD:735727 6480464 Ibuprofen inhibits the reaction [EGF protein results in increased expression of PLAU mRNA] CTD PMID:16340751 indole-3-methanol increases expression ISO RGD:735727 6480464 indole-3-carbinol results in increased expression of PLAU mRNA CTD PMID:18025290 indometacin increases expression ISO RGD:735727 6480464 Indomethacin results in increased expression of PLAU mRNA CTD PMID:16984733 indometacin multiple interactions ISO RGD:735727 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLAU mRNA; more ... CTD PMID:28628672 iron(III) nitrilotriacetate increases expression ISO RGD:735727 6480464 ferric nitrilotriacetate results in increased expression of PLAU mRNA CTD PMID:17571974 iron(III) nitrilotriacetate increases activity ISO RGD:735727 6480464 ferric nitrilotriacetate results in increased activity of PLAU mRNA CTD PMID:17571974 iron(III) nitrilotriacetate multiple interactions ISO RGD:735727 6480464 Deferoxamine inhibits the reaction [ferric nitrilotriacetate results in increased activity of PLAU mRNA]; more ... CTD PMID:17571974 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of PLAU mRNA CTD PMID:20211217 L-methionine multiple interactions ISO RGD:733174 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAU mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:735727 6480464 leflunomide results in increased expression of PLAU mRNA CTD PMID:28988120 lipopolysaccharide affects expression ISO RGD:735727 6480464 Lipopolysaccharides affects the expression of PLAU mRNA CTD PMID:28070326 lipopolysaccharide multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PLAU protein] CTD PMID:27098997 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PLAU protein CTD PMID:27098997 lipopolysaccharide increases expression ISO RGD:735727 6480464 Lipopolysaccharides results in increased expression of PLAU mRNA CTD PMID:18192897 lipopolysaccharide multiple interactions ISO RGD:735727 6480464 Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of PLAU mRNA] CTD PMID:28070326 lithium chloride decreases expression ISO RGD:735727 6480464 Lithium Chloride results in decreased expression of PLAU mRNA CTD PMID:15711924 lithium chloride increases expression ISO RGD:735727 6480464 Lithium Chloride results in increased expression of PLAU mRNA CTD PMID:23527032 LY294002 multiple interactions ISO RGD:735727 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [hispolon results in decreased expression of and results in decreased activity of PLAU protein] CTD PMID:27037602 mangiferin multiple interactions EXP 6480464 mangiferin inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] CTD PMID:19706694 medroxyprogesterone acetate decreases expression ISO RGD:735727 6480464 Medroxyprogesterone Acetate results in decreased expression of PLAU mRNA CTD PMID:20843944 methotrexate increases expression ISO RGD:735727 6480464 Methotrexate results in increased expression of PLAU mRNA CTD PMID:21678067 methotrexate decreases expression ISO RGD:735727 6480464 Methotrexate results in decreased expression of PLAU mRNA CTD PMID:24449571 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of PLAU mRNA CTD PMID:21782745 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of PLAU mRNA CTD PMID:21782745 methylmercury chloride increases expression ISO RGD:735727 6480464 methylmercuric chloride results in increased expression of PLAU mRNA CTD PMID:28001369 mitomycin C affects response to substance ISO RGD:735727 6480464 PLAU protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-acetyl-L-cysteine decreases expression ISO RGD:735727 6480464 Acetylcysteine results in decreased expression of PLAU mRNA CTD PMID:16084531 N-acetyl-L-cysteine multiple interactions ISO RGD:735727 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased secretion of PLAU protein] CTD PMID:15962302 N-nitrosodiethylamine increases expression ISO RGD:735727 6480464 Diethylnitrosamine results in increased expression of PLAU mRNA CTD PMID:21527772 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PLAU mRNA CTD PMID:25380136 N-tosyl-L-phenylalanyl chloromethyl ketone decreases expression ISO RGD:735727 6480464 Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of PLAU protein CTD PMID:10467400 nickel atom increases expression ISO RGD:735727 6480464 Nickel results in increased expression of PLAU mRNA CTD PMID:25583101 nickel sulfate multiple interactions ISO RGD:735727 6480464 [macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in decreased expression of PLAU mRNA CTD PMID:18832182 nickel sulfate decreases expression ISO RGD:735727 6480464 nickel sulfate results in decreased expression of PLAU mRNA CTD PMID:18832182 nicotine multiple interactions ISO RGD:735727 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of PLAU mRNA] CTD PMID:20061081 nicotine increases expression ISO RGD:735727 6480464 Nicotine results in increased expression of PLAU mRNA CTD PMID:20061081 PMID:23825647 nicotine multiple interactions ISO RGD:733174 6480464 PLAU inhibits the reaction [Nicotine binds to CHRNA1 protein] CTD PMID:19690163 notoginsenoside R1 increases expression ISO RGD:735727 6480464 notoginsenoside R1 results in increased expression of PLAU mRNA; more ... CTD PMID:9220151 ornidazole decreases expression EXP 6480464 Ornidazole results in decreased expression of PLAU mRNA; more ... CTD PMID:18998460 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PLAU mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLAU mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of PLAU mRNA CTD PMID:16716893 panobinostat multiple interactions ISO RGD:735727 6480464 [NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAU mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:735727 6480464 panobinostat results in increased expression of PLAU mRNA CTD PMID:26272509 paraquat increases expression EXP 6480464 Paraquat results in increased expression of PLAU mRNA CTD PMID:18198484 PD 0325901 multiple interactions ISO RGD:735727 6480464 [PD 0325901 co-treated with (+)-JQ1 compound] results in decreased expression of PLAU mRNA CTD PMID:25119042 PD 0325901 decreases expression ISO RGD:735727 6480464 PD 0325901 results in decreased expression of PLAU mRNA CTD PMID:25119042 pentane-2,3-dione increases expression EXP 6480464 2,3-pentanedione results in increased expression of PLAU mRNA CTD PMID:25710175 phenylmercury acetate increases expression ISO RGD:735727 6480464 Phenylmercuric Acetate results in increased expression of PLAU mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735727 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAU mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:735727 6480464 arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of PLAU protein] CTD PMID:15962302 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733174 6480464 TAC 101 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PLAU protein] CTD PMID:9848099 phorbol 13-acetate 12-myristate increases expression ISO RGD:733174 6480464 Tetradecanoylphorbol Acetate results in increased expression of PLAU protein CTD PMID:9848099 phorbol 13-acetate 12-myristate increases secretion ISO RGD:735727 6480464 Tetradecanoylphorbol Acetate results in increased secretion of PLAU protein CTD PMID:15962302 potassium chromate decreases expression ISO RGD:735727 6480464 potassium chromate(VI) results in decreased expression of PLAU mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:735727 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of PLAU mRNA; more ... CTD PMID:17404688 PMID:20660070 progesterone decreases expression ISO RGD:735727 6480464 Progesterone results in decreased expression of PLAU mRNA CTD PMID:17404688 PMID:18070364 propanal increases expression ISO RGD:735727 6480464 propionaldehyde results in increased expression of PLAU mRNA CTD PMID:26079696 pyrrolidine dithiocarbamate multiple interactions ISO RGD:735727 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased expression of PLAU mRNA] CTD PMID:16340751 quercetin decreases expression ISO RGD:735727 6480464 Quercetin results in decreased expression of PLAU mRNA; more ... CTD PMID:21308698 PMID:23645742 quercetin increases expression ISO RGD:735727 6480464 Quercetin results in increased expression of PLAU mRNA; more ... CTD PMID:11236827 PMID:12724357 quercetin increases expression EXP 6480464 Quercetin results in increased expression of PLAU mRNA CTD PMID:17478321 quercetin multiple interactions ISO RGD:735727 6480464 Dactinomycin inhibits the reaction [Quercetin results in increased expression of PLAU mRNA] CTD PMID:11236827 raloxifene multiple interactions ISO RGD:735727 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of PLAU mRNA CTD PMID:19059307 raloxifene decreases expression ISO RGD:735727 6480464 Raloxifene Hydrochloride results in decreased expression of PLAU protein CTD PMID:16277677 resveratrol multiple interactions ISO RGD:735727 6480464 Dactinomycin inhibits the reaction [resveratrol results in increased expression of PLAU mRNA]; more ... CTD PMID:11236827 more ... resveratrol decreases expression ISO RGD:735727 6480464 resveratrol results in decreased expression of PLAU mRNA; more ... CTD PMID:22199285 more ... resveratrol decreases activity ISO RGD:735727 6480464 resveratrol results in decreased activity of PLAU protein CTD PMID:25605016 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of PLAU mRNA CTD PMID:25905778 resveratrol increases expression ISO RGD:735727 6480464 resveratrol results in increased expression of PLAU mRNA; more ... CTD PMID:11236827 ryanodine multiple interactions ISO RGD:733174 6480464 Ryanodine promotes the reaction [Mustard Gas results in increased activity of PLAU protein] CTD PMID:9101041 SB 431542 increases expression ISO RGD:735727 6480464 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of PLAU mRNA CTD PMID:25670856 SB 431542 multiple interactions ISO RGD:735727 6480464 [NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAU mRNA; more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:733174 6480464 Asbestos, Serpentine results in increased expression of PLAU mRNA CTD PMID:23917077 silibinin multiple interactions ISO RGD:735727 6480464 [silybin co-treated with arsenic trioxide] results in decreased expression of PLAU mRNA; more ... CTD PMID:21969006 silibinin decreases expression ISO RGD:735727 6480464 silybin results in decreased expression of PLAU mRNA CTD PMID:21969006 silicon dioxide increases expression ISO RGD:735727 6480464 Silicon Dioxide analog results in increased expression of PLAU mRNA; more ... CTD PMID:25351596 PMID:25895662 silicon dioxide increases expression ISO RGD:733174 6480464 Silicon Dioxide results in increased expression of PLAU mRNA CTD PMID:19073995 silver atom increases expression ISO RGD:733174 6480464 Silver results in increased expression of PLAU mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:733174 6480464 Silver results in increased expression of PLAU mRNA CTD PMID:27131904 simvastatin decreases expression ISO RGD:733174 6480464 Simvastatin results in decreased expression of PLAU mRNA CTD PMID:10412775 sodium arsenite multiple interactions ISO RGD:735727 6480464 decitabine inhibits the reaction [sodium arsenite results in increased expression of PLAU mRNA]; more ... CTD PMID:21167264 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PLAU protein CTD PMID:21167264 sodium arsenite increases expression ISO RGD:735727 6480464 sodium arsenite results in increased expression of PLAU mRNA; more ... CTD PMID:21167264 sodium arsenite decreases expression ISO RGD:735727 6480464 sodium arsenite results in decreased expression of PLAU mRNA CTD PMID:12016162 PMID:25493608 sodium dichromate decreases expression ISO RGD:735727 6480464 sodium bichromate results in decreased expression of PLAU mRNA; more ... CTD PMID:10438662 PMID:17685462 sodium hydroxide affects response to substance ISO RGD:735727 6480464 PLAU SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27206134 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of PLAU mRNA; more ... CTD PMID:15322501 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of PLAU mRNA; more ... CTD PMID:15322501 PMID:25905778 succimer multiple interactions ISO RGD:733174 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAU mRNA CTD PMID:21641980 succimer multiple interactions ISO RGD:735727 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLAU mRNA CTD PMID:26378955 sulindac sulfide decreases expression ISO RGD:735727 6480464 sulindac sulfide results in decreased expression of PLAU mRNA CTD PMID:15767558 tamoxifen multiple interactions ISO RGD:735727 6480464 [Tamoxifen co-treated with ESR1 protein] results in decreased expression of PLAU mRNA CTD PMID:19059307 tebuconazole decreases expression ISO RGD:735727 6480464 tebuconazole results in decreased expression of PLAU mRNA CTD PMID:26852204 telmisartan multiple interactions EXP 6480464 telmisartan inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] CTD PMID:19706694 tetrachloromethane multiple interactions ISO RGD:733174 6480464 [Carbon Tetrachloride co-treated with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea] results in increased expression of PLAU mRNA; more ... CTD PMID:18279442 more ... tetrachloromethane increases expression ISO RGD:733174 6480464 Carbon Tetrachloride results in increased expression of PLAU mRNA CTD PMID:24639359 PMID:25827057 tetrachloromethane multiple interactions EXP 6480464 PLAU protein inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; more ... CTD PMID:18481824 thalidomide decreases expression ISO RGD:733174 6480464 Thalidomide results in decreased expression of PLAU protein CTD PMID:16288038 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLAU mRNA CTD PMID:25729387 trans-anethole decreases expression ISO RGD:735727 6480464 anethole results in decreased expression of PLAU mRNA CTD PMID:21212515 trans-resveratrol multiple interactions ISO RGD:735727 6480464 Dactinomycin inhibits the reaction [resveratrol results in increased expression of PLAU mRNA]; more ... CTD PMID:11236827 more ... trans-resveratrol decreases expression ISO RGD:735727 6480464 resveratrol results in decreased expression of PLAU mRNA; more ... CTD PMID:22199285 more ... trans-resveratrol decreases activity ISO RGD:735727 6480464 resveratrol results in decreased activity of PLAU protein CTD PMID:25605016 trans-resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of PLAU mRNA CTD PMID:25905778 trans-resveratrol increases expression ISO RGD:735727 6480464 resveratrol results in increased expression of PLAU mRNA; more ... CTD PMID:11236827 trichostatin A increases expression ISO RGD:735727 6480464 trichostatin A results in increased expression of PLAU mRNA CTD PMID:24935251 PMID:26272509 trichostatin A multiple interactions ISO RGD:735727 6480464 [NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAU mRNA CTD PMID:27188386 triclosan multiple interactions ISO RGD:735727 6480464 Triclosan inhibits the reaction [TNF protein results in increased activity of PLAU protein]; more ... CTD PMID:19874453 troglitazone increases expression ISO RGD:735727 6480464 troglitazone results in increased expression of PLAU mRNA CTD PMID:19140230 tubocurarine multiple interactions ISO RGD:733174 6480464 Tubocurarine inhibits the reaction [CHRNA1 protein binds to PLAU protein] CTD PMID:19690163 valproic acid increases expression ISO RGD:735727 6480464 Valproic Acid results in increased expression of PLAU mRNA CTD PMID:24383497 PMID:28001369 valproic acid affects expression ISO RGD:735727 6480464 Valproic Acid affects the expression of PLAU mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:735727 6480464 Valproic Acid results in increased methylation of PLAU gene CTD PMID:29154799 vanadium atom increases expression ISO RGD:735727 6480464 Vanadium results in increased expression of PLAU mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:735727 6480464 Vanadium results in increased expression of PLAU mRNA CTD PMID:19000753 vincaleukoblastine affects response to substance ISO RGD:735727 6480464 PLAU protein affects the susceptibility to Vinblastine CTD PMID:16217747 vorinostat multiple interactions ISO RGD:735727 6480464 [NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAU mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:735727 6480464 vorinostat results in increased expression of PLAU mRNA CTD PMID:26272509 zinc atom multiple interactions ISO RGD:735727 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PLAU mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:735727 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PLAU mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:735727 6480464 zoledronic acid results in increased expression of PLAU mRNA CTD PMID:20977926
Gene-Chemical Interaction Annotations
